Showing 3631-3640 of 4063 results for "".
- Alsanza Announces Global Launch of Alsee Zero Glistening, Zero Haze Hydrophobic Monofocal IOLhttps://modernod.com/news/alsanza-globally-launches-zero-glistening-zero-haze-hydrophobic-monofocal-iol-alsee/2478652/Germany-based Alsanza announced the launch of the Alsee Zero Glistening Zero Haze Hydrophobic Monofocal IOL. The Alsee IOL is developed and designed to provide long-term clarity and high-contrast sensitive quality of vision with its 24-hour aspheric optic design. Alsee Zero Glistening Zero
- MHRA Advises Against Use of Pfizer, BioNTech’s COVID-19 Vaccine in Those With “Significant History” of Allergic Reactionshttps://modernod.com/news/mhra-advises-against-use-of-pfizer-biontechs-covid-19-vaccine-in-those-with-significant-history-of-allergic-reactions/2478646/The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) on Wednesday warned that people who have a “significant history” of allergic reactions should not receive Pfizer and BioNTech’s COVID-19 vaccine BNT162b2. The regulator issued the alert because two NHS wor
- Biden Builds Out Health Team with Xavier Becerra Named to Lead HHShttps://modernod.com/news/biden-builds-out-health-team-with-xavier-becerra-named-to-lead-hhs/2478635/US President-elect Joe Biden released more of his health team picks on Monday, nominating California Attorney General Xavier Becerra to serve as Secretary of Health and Human Services (HHS). In addition, Vivek Murthy, who was the US Surgeon General from 2014 to 2017, has been selected to return t
- Effort To ‘End Blindness’ Marks Milestone With Leading Scientists Recognized For Pioneering Workhttps://modernod.com/news/effort-to-end-blindness-marks-milestone-with-leading-scientists-recognized-for-pioneering-work/2478623/End Blindness 2020, a joint effort by leading scientists and figures from the worlds of business, politics, culture, art, music and entertainment to rid the world of blindness, is about to mark a milestone. On December 14, 2020, 13 scientists will share
- John Weiss Secures Exclusive UK Distributorship for VRmagic’s Eyesi Surgical Medical Simulatorhttps://modernod.com/news/john-weiss-secures-exclusive-uk-distributorship-for-vrmagics-eyesi-surgical-medical-simulator/2478600/John Weiss & Son has announced it has secured an exclusive distributorship for the VRmagic Eyesi Surgical medical simulator. VRmagic was established in 2001 and is a provider of virtual and augmented reality technology in medical training. The solutions developed by VRmagic permit a re
- Oculus Names New Medical Directorhttps://modernod.com/news/oculus-names-new-medical-director/2478589/Oculus has announced that William Tullo, OD, FAAO, joined the company as a Medical Director on November 2nd, 2020. In this newly developed role, Dr. Tullo will provide clinical guidance and educate medical eye profess
- NovaBay Pharmaceuticals Expands Avenova’s Geographic Reach to Australia with New Exclusive Distribution Agreementhttps://modernod.com/news/novabay-pharmaceuticals-expands-avenovas-geographic-reach-to-australia-with-new-exclusive-distribution-agreement/2478586/NovaBay Pharmaceuticals announced the signing of an agreement with Paragon Care Group Australia Pty for the exclusive distribution of Avenova in Australia. Paragon Care Group will begin distributing Avenova directly to consumers under its Designs For Vision brand beginning in early 2021. “
- FDA Authorizes Regeneron’s Dual COVID-19 Antibody Treatment for Emergency Usehttps://modernod.com/news/fda-authorizes-regenerons-dual-covid-19-antibody-treatment-for-emergency-use/2478587/The FDA has issued an emergency-use authorization (EUA) to Regeneron’s filing for casirivimab and imdevimab to be administered together to treat mild-to-moderate COVID-19 in adults and paediatric patients. The monoclonal antibodies, also referred to as REGN-COV2 or as REGEN-COV2 when used i
- Hydrus Microstent Receives Highest Designation of Any MIGS Device as Part of AAO Treatment Guidelineshttps://modernod.com/news/hydrus-microstent-receives-highest-designation-of-any-migs-device-as-part-of-aao-treatment-guidelines/2478570/Ivantis, developer of the novel Hydrus Microstent MIGS device, announced that the American Academy of Ophthalmology (AAO) has designated the Hydrus Microstent as “Level 1, Moderate Quality, Strong Recommendation.” The designation is the highest of any MIGS device in its 2020 Preferred Practice Pa
- IRIS Registry Reveals Insights into Eye Disease Prevention and Treatmenthttps://modernod.com/news/worlds-largest-specialty-clinical-data-registry-reveals-insights-into-eye-disease-prevention-and-treatment/2478566/The IRIS Registry powered a number of big data studies this year, many of which were presented at AAO 2020 Virtual, the 124th annual meeting of the American Academy of Ophthalmology. The research findings are now available to view on demand. “With a growing pool of aggregated d